The BCR-ABL positive CML (Chronic Myeloid Leukaemia) cells also lower the expression of mlh1 and pms2 and induce point mutations thus affecting the mismatch repair mechanisms34,35. Here, PMS2 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.